NASDAQ:TNDM

Tandem Diabetes Care Stock News

etoro logo Buy TNDM
*Your capital is at risk
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Teladoc's solid position in telemedicine, improving bottom line, and strong margins make a solid case for the stock. Tandem Diabetes Care develops cutting-edge insulin pumps for diabetes patients, an
Tandem Diabetes' (TNDM) second-quarter 2023 performance reflects new technology innovations and operational improvements throughout its business.
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.24 per share a year ago.
CVS Health's broad array of healthcare services makes it an excellent long-term pick. Tandem Diabetes Care can still benefit from the vast untapped market within its niche.
Tandem Diabetes Care's stock is down 33% so far this year. The company got off to a sluggish first quarter.
Tandem Diabetes (TNDM) receives FDA clearance for the world's smallest AID system, Tandem Mobi.
Tandem Diabetes Care, Inc. (TNDM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further p
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2023 results af

7 Battered Stocks That Could TRIPLE by 2024

08:38pm, Monday, 03'rd Jul 2023
Battered stocks to buy usually represent the exclusive avenue of the extreme speculator. As many beginner investors often find out, you don't want to take the buy low, sell high adage blindly without
Tandem Diabetes Care experienced a Q1 2023 financial downturn, yet expects a 10%-12% annual growth rate. Despite weak recent stock performance, Tandem exhibits a robust growth profile but faces profit
Ordinarily, a blisteringly hot jobs report wouldn't inspire discussions about stocks to buy before crash. Essentially, the latest employment readout suggested that more money chases after fewer goods.
Novo Nordisk's expertise in diabetes care is about to produce another promising medicine. Tandem Diabetes Care is looking to take advantage of the vast insulin-pump opportunity.
Investors continue to be optimistic about Tandem Diabetes (TNDM) based on the strong performance of the t:slim X2 insulin pump.
According to Tandem Diabetes (TNDM), Q1 revenues are in line with the high end of its expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE